Study guide
3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels
BCSCP Board Certified Sterile Compounding Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, USP Standards & CSP Categories
1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions
2 Chapter 2: Facilities, Engineering Controls & Cleaning
2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures
3 Chapter 3: Environmental Monitoring & Facility Certification
3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols
4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique
4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity
5 Chapter 5: Beyond-Use Dating, Storage & Container Rules
5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules
6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding
6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)
7 Chapter 7: Materials, Equipment & Compounding Workflow
7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs
8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility
8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics
9 Chapter 9: Therapeutics, Administration & Patient Monitoring
9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations
10 Chapter 10: Quality Management, Records & Personnel Competency
10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence
11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain
11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA
12 Chapter 12: Safety Management, Investigations, Recalls & Waste
12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management
3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels
Key Takeaways Explain This Topic AI
Surface sampling evaluates cleaning and disinfection and personnel work practices by measuring viable bioburden on classified-area surfaces, including the inside of each PEC and pass-through chambers.
Sampling should occur at the end of compounding (or of a shift) and before routine cleaning and disinfection, so it reflects the real challenge.
Surface sampling devices contain a general growth medium such as TSA with neutralizing additives (for example, lecithin and polysorbate 80) and have a raised convex surface.
Surface action levels are > 3 CFU per device for ISO Class 5, > 5 for ISO Class 7 and > 50 for ISO Class 8. Sampling is at least monthly for Categories 1 and 2, and at least weekly plus after every batch in the PEC for Category 3.
After sampling, the sampled area must be thoroughly cleaned and disinfected to remove agar residue.
Last updated: September 2026
Purpose and Timing of Surface Microbial Sampling
While air sampling monitors the dilution and filtration efficiency of the ventilation system, surface sampling provides a direct measure of microbial bioburden transferred to cleanroom surfaces by human touch, supply introduction, and surface deposition. Surface sampling verifies the adequacy of personnel work practices, garbing integrity, and facility cleaning and disinfecting procedures.
Operational Timing: End of Compounding
USP <797> mandates that routine surface sampling must be conducted at the conclusion of compounding or at the end of an operating shift, prior to cleaning and disinfecting .
Important
Sampling immediately after sanitization measures only the instantaneous germicidal effect of the disinfectant, producing artificially low counts. Sampling at the end of active operations captures the true microbial challenge accumulated during compounding and reflects actual patient risk.
- Sampling Devices and Techniques
- 1. Contact Plates (RODAC Plates)
Application : Used for flat, accessible surfaces such as PEC work tables, staging countertops, pass-through chambers, equipment housing, and door handles.
Design : Replicate Organism Detection and Counting (RODAC) plates have a convex meniscus of agar that rises slightly above the rim of the plastic dish.
Technique : The plate is pressed gently against the target surface with uniform pressure for 3 to 5 seconds without twisting or sliding (which smudges colonies and damages agar).
Mandatory Post-Sampling Cleaning : After sampling, the sampled area must be thoroughly cleaned and disinfected (USP <797> 6.3.2), followed by sterile 70% IPA if it is inside a PEC. Agar left on a surface is a nutrient bed for microbes.
2. Sterile Swabs
Application : Used for irregular, grooved, creviced, or confined surfaces where a rigid contact plate cannot make complete physical contact (e.g., inside IV compounding automated pumps, electrical outlet bezels, seams, and glove box glove rings).
Technique : A sterile swab moistened with sterile diluent (such as sterile peptone water or phosphate buffer with neutralizers) is rubbed firmly across the target area in multiple intersecting directions, then streaked onto an agar plate.
Mandatory Surface Sampling Frequencies
- Operational Tier Minimum Mandated Surface Sampling Frequency
- Category 1 Facilities Monthly
- Category 2 Facilities Monthly
Category 3 Facilities At least weekly, and before any Category 3 BUD is first assigned; plus inside the PEC at the end of each batch, before cleaning (at least daily for a self-enclosed robotic device)
- All Facilities (Ad Hoc) In response to microbial excursions, construction, or personnel contamination events
- Surface Microbial Action Levels
Under USP <797>, action levels for surface sampling are expressed in colony-forming units (CFUs) per contact plate (standard surface area of approximately 24 to 30 cm 2 24\text{ to }30\,\text{cm}^2 24 to 30 cm 2 ):
- Environment Cleanliness Classification Surface Microbial Action Level (CFU/plate)
- Primary Engineering Control (PEC) ISO Class 5 > 3 CFU
- Buffer Area ISO Class 7 > 5 CFU
- Ante-room ISO Class 8 (or ISO 7) > 50 CFU
Pass-through chamber Connects two classes USP names no class; the SOP chooses the ISO 7 or ISO 8 limit (USP FAQ)
Incubation Parameters
Surface devices use the same incubation as air samples: 30°C–35°C for no less than 48 hours , then 20°C–25°C for no less than 5 additional days . The alternative is two devices incubated concurrently at the two temperatures. If two devices are collected at one location, the action level applies to each device separately; the counts are not added.
Neutralizer Chemistry and Inactivation Kinetics
Cleanroom surfaces are subjected to routine chemical disinfection with quaternary ammonium compounds, phenolics, sodium hypochlorite, and isopropyl alcohol. Residual amounts of these antimicrobial chemicals adhere to cleanroom surfaces and are picked up onto the agar during sampling.
If surface sampling were conducted using standard Trypticase Soy Agar (TSA) without neutralizing agents, residual disinfectants would continue to exert bacteriostatic or fungistatic action inside the Petri dish during incubation. Viable microorganisms present on the surface would be prevented from replicating, producing a false-negative culture report that conceals environmental contamination.
To ensure accurate recovery, USP <797> requires surface sampling media to contain neutralizing additives , naming lecithin and polysorbate 80 as examples. Commercial media may add others:
Lecithin : Neutralizes quaternary ammonium compounds (QACs) and biguanides (e.g., chlorhexidine).
Polysorbate 80 (Tween 80) : Inactivates phenolic disinfectants, hexachlorophene, and formalin.
Sodium Thiosulfate : Neutralizes halogenated disinfectants including sodium hypochlorite (bleach), iodine, and chlorine dioxide.
Personnel Gloved Fingertip and Thumb Sampling (GFT)
Personnel glove testing measures the touch contamination risk introduced directly by compounding operators. A contact plate is held, and the operator presses all five digits (thumb and four fingers) lightly onto the agar surface for 2 to 3 seconds.
USP <797> uses gloved fingertip testing in three settings, with two different action levels:
1. Initial Garbing Competency
Conducted immediately after garbing, inside a classified area or SCA, before sterile 70% IPA is applied to the gloves .
The operator must pass three separate, successive evaluations , each after a complete hand hygiene and garbing procedure.
Action level : > 0 CFU total for both hands. Any growth is a failure.
2. Ongoing Garbing Competency
Repeated at least every 6 months (Category 1 and 2 compounders) or every 3 months (Category 3), and every 12 months for supervisors who do not compound.
It is the same test: visual observation plus GFT after garbing, before IPA. The action level stays > 0 CFU .
3. GFT After a Media-Fill Test
Part of the aseptic manipulation competency, taken inside the ISO Class 5 PEC immediately after the media fill .
Action level : > 3 CFU total for both hands combined. A media-fill, GFT or direct-compounding-area surface sample failure fails the whole competency.
USP does not require microbial identification of GFT colonies, although identification can help an investigation.